Skip to Content
  • Previous Rank
  • Revenues ($M)
  • Revenue Percent Change
  • Profits ($M)
  • Profits Percent Change
  • Assets ($M)
  • Employees
  • Market Value — as of March 29, 2018 ($M)

In December Walgreen’s announced a 40% stake in Sinopharm Holding Guoda Drugstores in China, expanding the company’s global reach. And the pharma retailer is getting into the data game, having spent over $500 million to-date on updating pharmacy management and data collection system and turning its 88.6 million user “Balance Rewards” program into a customer insight tool. Despite these expansion efforts and stronger than expected Q2 earnings, shareholders have watched the pharma retailer’s share price drop 22% since January, largely due to Amazon’s plan to sell prescription drugs to doctors and hospitals.

Company Info

Figures are for fiscal year ended Aug. 31, 2017.
Stefano Pessina
CEO Title
Vice Chairman & Chief Executive Officer
Food & Drug Stores
Food and Drug Stores
HQ Location
Deerfield, Ill.
Years on Fortune 500 List24
Created with sketchtool.Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Purchase Now

Walgreens Boots Alliance Rank History


Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$118,214.000.7%
Profits ($M)$4,078.00-2.3%
Assets ($M)$66,009.00-
Total Stockholder Equity ($M)$27,466.00-
Market Value — as of March 29, 2018 ($M)$64,924.30-

Profit Ratios

Profit as % of Revenues3.4%
Profits as % of Assets6.2%
Profits as % of Stockholder Equity14.8%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)3.78
EPS % Change (from 2016)-1%
EPS % Change (5 year annual rate)9.3%
EPS % Change (10 year annual rate)6.4%

Total Return

Total Return to Investors (2017)-10.5%
Total Return to Investors (5 year, annualized)16.6%
Total Return to Investors (10 year, annualized)8.8%